High-density lipoprotein: Relations to metabolic parameters and severity of coronary artery disease

Metabolism: Clinical and Experimental

Volumn 45, Issue 11, 1996, Pages 1375-1382

  Tornvall, Per ^a   Karpe, Fredrik ^b   Proudler, Anthony ^b   Båvenholm, Peter ^b   Landou, Christian ^b   Olivecrona, Thomas ^b   Hamsten, Anders ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; BODY MASS; CHOLESTEROL TRANSPORT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DISEASE SEVERITY; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; PRIORITY JOURNAL;

EID: 0029822679     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90118-3     Document Type: Article

References (34)

1. NIH Consensus Development Panel on Triglyceride, High Density Lipoprotein and Coronary Heart Disease: Triglyceride, high-density lipoprotein and coronary heart disease. JAMA 269:505-510, 1993
2. Forte TM, McCall MR: The role of apolipoprotein A-1-containing lipoproteins in atherosclerosis. Curr Opin Lipidol 5:354-364, 1994
3. Carlsson LA, Ericsson M: Quantitative and qualitative serum lipoprotein analysis. I. Studies in healthy men and women. Atherosclerosis 21:417-433, 1975
4. 2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 80:341-347, 1987
5. Parthasarathy S, Barnett J, Fong LG: High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1044:275-283, 1990
6. Taskinen M-R, Kuusi T: Enzymes involved in triglyceride hydrolysis. Ballieres Clin Endocrinol Metab 639-666, 1987
7. Eisenberg S: High density lipoprotein metabolism. J Lipid Res 25:1017-1058, 1984
8. Barter PJ, Hopkins GJ, Ha YC: The role of lipid transfer proteins in plasma lipoprotein metabolism. Am Heart J 113:538-542, 1987
9. Hamsten A, Walldius G, Dahlen G, et al: Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis 59:223-235, 1986
10. Tornvall P, Båvenholm P, Landou C, et al: Relationship of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation 88:2180-2189, 1993
11. Tornvall P, Bengtsson-Olivecrona G, Karpe F, et al: Lipoprotein lipase mass and activity in plasma and increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 15:1086-1093, 1995
12. Båvenholm P, Proudler AJ, Tornvall P, et al: Insulin, intact and split proinsulin and coronary artery disease in young men. Circulation 9:1422-1429, 1995
13. Blanche PJ, Gong EL, Forte TM, et al: Characterization of human high density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 665:408-419, 1981
14. Carlson K: Lipoprotein fractionation. J Clin Pathol 26:32-37, 1973
15. Zlatkis A, Zak B, Boyle A: A new method for direct determination of serum cholesterol. J Lab Clin Med 41:486-492, 1953
16. Fletcher MJ: A colorimetric method for estimating serum triglycerides. Clin Chim Acta 22:393-397, 1968
17. Carlson LA: Extraction of lipids from human whole serum and lipoproteins and from rat liver tissue with methylene chloride-methanol: A comparison with extraction with chloroform methanol. Clin Chim Acta 149:89-93, 1985
18. Karpe F, Olivecrona T, Walldius G, et al: Lipoprotein lipase in plasma after an oral fat load: Relation to free fatty acids. J Lipid Res 33:975-984, 1992
19. Karpe F, Tornvall P, Olivecrona T, et al: Composition of human low density lipoprotein: Effects of postprandial triglyceriderich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis 98:33-49, 1993
20. Blanche PJ, Long EL, Forte TM, et al: Characterization of human high density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 665:408-419, 1981
21. Proudler AJ, Godsland IF, Stevenson JC: Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurements. Metabolism 43:446-449, 1994
22. Hamsten A, Walldius G, Szamosi A, et al: Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation 73:1097-1110, 1986
23. 2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler Thromb 12:814-823, 1992
24. Kuusi T, Ehnholm C, Viikari J, et al: Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res 30:1117-1126, 1989
25. Applebaum-Bowden D, Haffner SM, Wahl PW, et al: Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein 2 cholesterol. Arteriosclerosis 5:273-282, 1985
26. Syvänne M, Ahola M, Lahdenperä S, et al: High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 36:573-582, 1995
27. Cohen JC, Wang Z, Grundy SM, et al: Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 94:2377-2384, 1994
28. McPherson R, Mann CJ, Tall AR, et al: Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 11:797-804, 1991
29. Austin MA, King M-C, Vranizan KM, et al: Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82:495-506, 1990
30. Johansson J, Carlson LA, Landou C, et al: High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 86:111-122, 1991
31. Roberts WC: Recent studies on the effects of beta blockers on blood lipid levels. Am Heart J 117:709-714, 1989
32. Marotta T, Aldo Ferrara L, Di Marino L, et al: Factors affecting lipoprotein lipase in hypertensive patients. Metabolism 44:712-718, 1995
33. Lithell H, Pollare T, Vessby B: Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients. Blood Pressure 1:92-101, 1992
34. Rubba P, De Simone B, Marotta T, et al: Adrenergic blocking agents and lipoprotein lipase activity. J Endocrinol Invest 12:119-122, 1989